Cargando…
P2-type purinergic signaling in the regulation of pancreatic β-cell functional plasticity as a promising novel therapeutic approach for the treatment of type 2 diabetes?
Diabetes Mellitus is a metabolic disorder characterized by a chronic hyperglycemia due to an impaired insulin secretion and a decreased in peripheral insulin sensitivity. This disease is a major public health problem due to it sharp prevalence. Therefore, it is crucial to readapt therapeutic approac...
Autores principales: | Mesto, Nour, Movassat, Jamileh, Tourrel-Cuzin, Cécile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099247/ https://www.ncbi.nlm.nih.gov/pubmed/37065173 http://dx.doi.org/10.3389/fendo.2022.1099152 |
Ejemplares similares
-
Activation of the GLP-1 Receptor Signalling Pathway: A Relevant Strategy to Repair a Deficient Beta-Cell Mass
por: Portha, Bernard, et al.
Publicado: (2011) -
Review: Pancreatic β-Cell Neogenesis Revisited
por: Paris, Maryline, et al.
Publicado: (2004) -
COUP-TFII Controls Mouse Pancreatic β-Cell Mass through GLP-1-β-Catenin Signaling Pathways
por: Boutant, Marie, et al.
Publicado: (2012) -
O-GlcNacylation Links TxNIP to Inflammasome Activation in Pancreatic β Cells
por: Filhoulaud, Gaelle, et al.
Publicado: (2019) -
Purinergic signalling in bone
por: Rumney, Robin M. H., et al.
Publicado: (2012)